logo

For the Inventor, By the Inventor

Worcester, MA, United States of America

Athena Diagnostics, Inc.

Calculating rank
USPTO Granted Patents = 23

% Expired Patents = 17.4



Trademarks = 9

Forward Citations = 31

Loading Chart...
Loading Chart...

40 inventors (with patents filed for the assignee):

goldMedal Corey D Braastad (9 out of 10 patents)

silverMedal Jeffrey George Jones (9 out of 10 patents)

bronzeMedal William K Seltzer (8 out of 8 patents)

4.  Susan Kimberly Allen (8 out of 8 patents)

5.  Sat Dev Batish (6 out of 6 patents)

6.  Normand J Robichaud (6 out of 6 patents)

7.  Narasimhan Nagan (5 out of 11 patents)

8.  Hui Zhu (5 out of 6 patents)

9.  Terry J Watnick (3 out of 6 patents)

10.  Jeffery G Jones (3 out of 3 patents)

11.  Gregory G Germino (3 out of 9 patents)

12.  David A Hill (3 out of 3 patents)

13.  Matthew Evans (3 out of 6 patents)

14.  John A Curran (3 out of 3 patents)

15.  Jing Wang (3 out of 3 patents)


23 patents:

1. 12497658 - METHODS TO DETECT A SILENT CARRIER GENOTYPE (2025-12-16),
2. 11655508 - PKD mutations and evaluation of same (2023-05-23),
3. 11512352 - Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2) (2022-11-29),
4. 10762981 - Pathogenicity scoring system for human clinical genetics (2020-09-01),
5. 10760128 - PKD mutations and evaluation of same (2020-09-01),
6. 10697016 - Methods to detect a silent carrier genotype (2020-06-30),
7. 10227650 - Methods to detect a silent carrier of a null allele genotype (2019-03-12),
8. 9611512 - Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2) (2017-04-04),
9. 8785122 - Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2) (2014-07-22),
10. 8771946 - PKD mutations and evaluation of same (2014-07-08),
11. 8192933 - Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2) (2012-06-05),
12. 7824860 - Application of aprataxin gene to diagnosis and treatment for early-onset spinocerebellar ataxia (EAOH) (2010-11-02),
13. 7799529 - Nephrin gene and protein (2010-09-21),
14. 7704691 - Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2) (2010-04-27),
15. 7521190 - Compositions and methods for genetic analysis of polycystic kidney disease (2009-04-21),
Company Overview
Athena Diagnostics, Inc. is a leader in the field of genetic testing, specializing in the development of diagnostic solutions for neurological disorders. The company focuses on providing comprehensive testing services that aid in the diagnosis of conditions such as epilepsy, neuromuscular diseases, and other genetic disorders. Based in Worcester, MA, Athena Diagnostics leverages advanced molecular technologies to enhance patient care and support healthcare professionals in making informed decisions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

Athena Diagnostics, Inc. USPTO Patent Assignee Logo
23 Patents

#15 in Worcester, MA

#870 in Massachusetts

#14,450 in US

#27,736 in the World

Worcester, MA (US)
Worcester, MA, United States of America

Athena Diagnostics, Inc.

Forward Citations = 31

40 inventors:

goldMedal Corey D Braastad (9 out of 10 patents)

silverMedal Jeffrey George Jones (9 out of 10 patents)

bronzeMedal William K Seltzer (8 out of 8 patents)

4.  Susan Kimberly Allen (8 out of 8 patents)

5.  Sat Dev Batish (6 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Athena Diagnostics, Inc.. Retrieved from https://idiyas.com/company/athena-diagnostics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…